72
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Assessing Individual Risk for High-Risk Early Colorectal Neoplasm for Pre-Selection of Screening in Shanghai, China: A Population-Based Nested Case–Control Study

, , , , , , , , , & show all
Pages 3867-3878 | Published online: 12 May 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.30207593
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442.29313949
  • Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi:10.1016/j.canlet.2017.04.024.28476483
  • Zhang L, Cao F, Zhang GY, et al. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025. Front Oncol. 2019;9:98. doi:10.3389/fonc.2019.0009830847304
  • Lieberman D, Ladabaum U, Cruz-Correa M, et al. Screening for colorectal cancer and evolving issues for physicians and patients: a review. JAMA. 2016;316(20):2035–2045. doi:10.1001/jama.2016.17418
  • Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193. doi:10.3322/caac.2139528248415
  • Dekker E, Rex DK. Advances in CRC prevention: screening and surveillance. Gastroenterology. 2018;154(7):1970–1984. doi:10.1053/j.gastro.2018.01.069.29454795
  • Gong Y, Bao P, Zhong W, et al. The implementation and first-round results of a community-based colorectal cancer screening program in Shanghai, China. Oncologist. 2018;23(8):928–935. doi:10.1634/theoncologist.2017-045129540604
  • Klabunde Carrie N, Joseph Djenaba A, King Jessica B, et al. Vital signs: colorectal cancer screening test use – United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881–888.24196665
  • Bretthauer M, Kaminski MF, Løberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176(7):894–902. doi:10.1001/jamainternmed.2016.0960.27214731
  • Chen H, Li N, Ren J; group of Cancer Screening Program in Urban China (CanSPUC), et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–1457. doi:10.1136/gutjnl-2018-317124.30377193
  • Klabunde C, Blom J, Bulliard JL, et al. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22(3):119–126. doi:10.1177/096914131558469425967088
  • An J, Sun Z, Li Y, Lu X, Ji G. Literature review and consideration of factors influencing colorectal cancer screening in China. Chin Gen Prac. 2020;23(23):2877–2882. doi:10.12114/j.issn.1007-9572.2020.00.160
  • Yuan P, Gu J. Meta-analysis of the compliance of colorectal cancer screening in China, 2006~2015. China Cancer. 2017;26(4):241–248. doi: 10.11735/j.issn.1004-0242.2017.04.A001
  • Li XP, Qian MC, Zhao GM, et al. The performance of a community-based colorectal cancer screening program: evidence from Shanghai Pudong New Area, China. Prev Med. 2019;118:243–250. doi:10.1016/j.ypmed.2018.11.00230412744
  • Driver JA, Gaziano JM, Gelber RP, et al. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120(3):257–263. doi:10.1016/j.amjmed.2006.05.055.17349449
  • Ma E, Sasazuki S, Iwasaki M, Sawada N, Inoue M, Tsugane S. Japan Public Health Center-based Prospective Study Group. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34(5):534–541. doi:10.1016/j.canep.2010.04.02120554262
  • Taylor DP, Stoddard GJ, Burt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med. 2011;13(5):385–391. doi:10.1097/GIM.0b013e318206438421270638
  • Yarnall JM, Crouch DJM, Lewis CM. Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer. Cancer Epidemiol. 2013;37:324–329. doi:10.1016/j.canep.2012.12.00823375517
  • Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175(6):584–593. doi:10.1093/aje/kwr33722328705
  • Dunlop MG, Tenesa A, Farrington SM, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 2013;62(6):871–881. doi:10.1136/gutjnl-2011-30053722490517
  • Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12(3):478–485. doi:10.1016/j.cgh.2013.08.042.24022090
  • Aniwan S, Rerknimitr R, Kongkam P, et al. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants. Gastrointest Endosc. 2015;81(3):719–727. doi:10.1016/j.gie.2014.11.03525708760
  • Hsu L, Jeon J, Brenner H, et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology. 2015;148(7):1330–1339.e14. doi:10.1053/j.gastro.2015.02.01025683114
  • Cooper JA, Parsons N, Stinton C, et al. Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model. Br J Cancer. 2018;118(2):285–293. doi:10.1038/bjc.2017.37529096402
  • Ibáñez -sanz G, Diez-Villanueva A, Alonso MH, et al. Risk model for colorectal cancer in Spanish population using environmental and genetic factors: results from the MCC-Spain study. Sci Rep. 2017;7:43263. doi:10.1038/srep43263.28233817
  • Li W, Zhao LZ, Ma DW, et al. Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test. Medicine (Baltimore). 2018;97:e0529. doi:10.1097/MD.000000000001052929718843
  • Jeon J, Du MM, Schoen RE, et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154(8):2152–2164. doi:10.1053/j.gastro.2018.02.02129458155
  • Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98(12):2648–2654. doi:10.1111/j.1572-0241.2003.08771.x14687811
  • Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236–1241. doi:10.1136/gut.2010.22116821402615
  • Chen G, Mao B, Pan Q, Liu Q, Xu X, Ning Y. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chin J Cancer Res. 2014;26(1):4–11. doi:10.3978/j.issn.1000-9604.2014.02.0324653621
  • Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63(7):1112–1119. doi:10.1136/gutjnl-2013-30496524385598
  • Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014;63(3):466–471. doi:10.1136/gutjnl-2013-30501323964098
  • Auge JM, Pellise M, Escudero JM, et al. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Gastroenterology. 2014;147(3):628–636.e1. doi:10.1053/j.gastro.2014.06.00824937264
  • Usher-Smith JA, Walter FM, Emery JD, et al. Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res. 2016;9(1):13–26. doi:10.1158/1940-6207.CAPR-15-0274
  • Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev. 2012;21:398–410. doi:10.1158/1055-9965.EPI-11-077122169185
  • Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–34.e1. doi:10.1016/j.cgh.2014.01.04224534546
  • Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol. 2006;6(1):5. doi:10.1186/1471-230X-6-516412216
  • Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: a dose–response meta-analysis of published cohort studies. Int J Cancer. 2007;120(3):664–671. doi:10.1002/ijc.2229917096321
  • Lieberman DA, Prindiville S, Weiss DG, Willett W, VA Cooperative Study Group 380. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290(22):2959–2967. doi:10.1001/jama.290.22.295914665657
  • Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, et al. Effects of family history on relative and absolute risks for colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(13):2657–2667.e9. doi:10.1016/j.cgh.2019.09.00731525516
  • Choi YJ, Lee DH, Han KD, et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS One. 2017;12(10):e0185778. doi:10.1371/journal.pone.018577828973012
  • Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300(23):2765–2778. doi:10.1001/jama.2008.83919088354
  • Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933–947. doi:10.1136/gutjnl-2013-30470123481261
  • Soltani G, Poursheikhani A, Yassi M, Hayatbakhsh A, Kerachian M, Kerachian MA. Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocr Disord. 2019;19(1):113. doi:10.1186/s12902-019-0444-631664994
  • Stegeman I, Bossuyt PM. Cancer risk models and preselection for screening. Cancer Epidemiol. 2012;36(5):461–469. doi:10.1016/j.canep.2012.06.01022841151
  • Goyal H, Mann R, Gandhi Z, et al. Scope of artificial intelligence in screening and diagnosis of colorectal cancer. J Clin Med. 2020;9(10):3313. doi:10.3390/jcm9103313